Population as of 1 November, number by age, sex, year, and region. by Dainty Ei (22265317)

Subjects:

Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2020. by Dainty Ei (22265317)

Subjects:

Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> hearts show decreased cardiomyocyte cross-sectional area. by Jennifer L. Carleton (22208916)

Subjects:

Demographic information of participants. by Zixia Bu (21475019)

Subjects:

Total organic carbon and phenolic content of raw materials and fruit body cultivated (see S2 in S2 File for reference). by Caglar Akcay (6910697)

Subjects:

Spawn run time, earliness, yield, biological efficiency and dry matter of mushroom fruit body (see S1 in S2 File for reference). by Caglar Akcay (6910697)

Subjects:

S2 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

S1 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects:

Elemental analysis of substrates and fruit bodies cultivated. by Caglar Akcay (6910697)

Subjects:

Substrate codes and ratios used in the study. by Caglar Akcay (6910697)

Subjects:

FT-IR results. by Caglar Akcay (6910697)

Subjects:

FT-IR results. by Caglar Akcay (6910697)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

FT-IR results. by Caglar Akcay (6910697)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

FT-IR results. by Caglar Akcay (6910697)

Subjects: